CXI Healthcare Technology schedules annual shareholders meeting
Bitget2026/10/08 08:30CXI Healthcare Technology Group will hold its annual general meeting on Oct. 28, 2026, at 10:00 a.m. in Seoul. Shareholders will vote on approval of financial statements for the year ended June 30, 2026. Agenda includes re-election of two internal directors, re-election of the auditor, director and auditor pay caps, subsidiary liquidation plan. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CXI Healthcare Technology Group Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008900656), on October 08, 2026, and is solely responsible for the information contained therein.
- CXI Healthcare Technology Group will hold its annual general meeting on Oct. 28, 2026, at 10:00 a.m. in Seoul.
- Shareholders will vote on approval of financial statements for the year ended June 30, 2026.
- Agenda includes re-election of two internal directors, re-election of the auditor, director and auditor pay caps, subsidiary liquidation plan.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.

Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
